Unicycive Therapeutics, Inc. SEC filings UNCY
Unicycive Therapeutics, Inc. has 307 filings in SEC EDGAR's recent list, going back to Mar 4, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Other events
|
Sep 29, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Other events
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 19, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 5, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Other events
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Other events
|
Aug 18, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Other events
|
Aug 15, 2025 | Aug 15, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Other events
|
Jul 8, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 20, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Other events
|
Jun 10, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Other events
|
May 21, 2025 | May 21, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Apr 14, 2025 | Mar 13, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Nov 12, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Other events
|
Sep 25, 2024 | Sep 24, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 15, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 15, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 2, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 26, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 25, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Mar 14, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
|
Mar 14, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Other events
|
Feb 21, 2024 | Feb 21, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Other events
|
Oct 23, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 25, 2023 | Sep 19, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 6, 2023 | Sep 5, 2023 |
| 8-K |
Current report
Auditor change
|
Aug 31, 2023 | Aug 28, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2023 | Aug 14, 2023 |
| 8-K |
Current report
Auditor change
|
Jul 31, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Other events
|
Jul 26, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Other events
|
Jun 30, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Listing notice
|
May 23, 2023 | May 17, 2023 |
| 8-K |
Current report
Results of operations
|
May 16, 2023 | May 16, 2023 |
| 8-K |
Current report
Material agreement
|
Apr 10, 2023 | Apr 6, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 30, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Mar 6, 2023 | Mar 3, 2023 |
| 8-K |
Current report
Other events
|
Mar 2, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Listing notice
|
Feb 7, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 2, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Agreement ended
|
Dec 29, 2022 | Dec 29, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 28, 2022 | Dec 28, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Listing notice
|
Aug 8, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 18, 2022 | Jul 14, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Other events
|
Nov 29, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
Showing 71 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- UNCY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1766140
- Former names
- Unicycive Therapeutics, Inc. (until Oct 29, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.